...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: AACR 2019
4
Feb 27, 2019 10:45PM

Feb 28, 2019 06:30AM

"Bear,,,, can we assume this is the preamble or basis for the Pfizer + RVX combo trial which we expect to be started this quarter??..."

No, this AACR poster is for the prostate cancer program, not the pending breast cancer program.

BearDownAZ

3
Feb 28, 2019 10:18AM
1
Feb 28, 2019 11:26AM
2
Feb 28, 2019 11:39AM
2
Feb 28, 2019 11:46AM
1
Feb 28, 2019 11:46AM
3
Feb 28, 2019 01:48PM
7
Feb 28, 2019 02:07PM
Share
New Message
Please login to post a reply